ScholarLens Back to search
2003•European Journal of CancerRequires access

Efficacy of tamoxifen following anastrozole (‘Arimidex’) compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women

Beat Thürlimann, J.F.R. Robertson, Jean‐Marc Nabholtz, Aman U. Buzdar, Jacques Bonneterre

Open publisher page 89 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 89 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Anastrozole, Tamoxifen, Medicine, Breast cancer, Oncology, Internal medicine, Antiestrogen, Gynecology

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Efficacy of tamoxifen following anastrozole (‘Arimidex’) compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women — Research Paper | ScholarLens